Qure.ai Granted FDA Approval for AI-Powered Lung Cancer Analysis Technology nextdigitalhealth.com

A leading global innovator in medical imaging, Qure.ai, has received pivotal 510(k) FDA approval for an AI-powered chest CT solution called qCT LN Quant to help radiologists and pulmonologists quantify lung nodules.

The FDA clearance allows medical specialists to use the technology to analyze lung nodules on non-contrast chest CT scans and monitor progression by tracking the volumetric growth of the nodules.